Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXM0AC
|
||||
| Drug Name |
(S)-1-[(2R,4S)-4-(4-Methoxy-benzo[b]thiophen-2-yl)-2-methyl-piperidin-1-yl]-3-(2-methyl-benzofuran-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL338777
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H31NO4S
|
||||
| Canonical SMILES |
COc1cccc2sc(cc12)[C@H]3CCN(C[C@H](O)COc4cccc5oc(C)cc45)[C@H](C)C3
|
||||
| InChI |
InChI=1S/C27H31NO4S/c1-17-12-19(27-14-22-23(30-3)6-5-9-26(22)33-27)10-11-28(17)15-20(29)16-31-24-7-4-8-25-21(24)13-18(2)32-25/h4-9,13-14,17,19-20,29H,10-12,15-16H2,1-3H3/t17-,19+,20+/m1/s1
|
||||
| InChIKey |
NNWMNOCTZDIGBT-HOJAQTOUSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.